Ladenburg Thalmann Financial Services’s GenMark Diagnostics, Inc GNMK Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$5K	Sell	1,000 -3,195	-76%	-$17.6K	﹤0.01%	4818
2019 Q3	$25K	Hold	4,195	–	–	﹤0.01%	3910
2019 Q2	$27K	Sell	4,195 -271	-6%	-$1.91K	﹤0.01%	3875
2019 Q1	$31K	Buy	4,466 +2,466	+123%	+$16.2K	﹤0.01%	3742
2018 Q4	$10K	Hold	2,000	–	–	﹤0.01%	4305
2018 Q3	$15K	Hold	2,000	–	–	﹤0.01%	4084
2018 Q2	$11K	Hold	2,000	–	–	﹤0.01%	4220
2018 Q1	$11K	Buy	+2,000	New	+$9.94K	﹤0.01%	4220

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ladenburg Thalmann Financial Services's GNMK Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its GenMark Diagnostics, Inc (GNMK) stake by 76% in Q4 2019, selling an estimated $17.6K and leaving 1,000 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #4818.

Ladenburg Thalmann Financial Services first reported a position in GNMK in Q1 2018 and has held it in 8 quarters since. The position peaked at $31K in Q1 2019. 111 funds tracked by Wall St. Rank hold GNMK as of Q4 2019.

Ladenburg Thalmann Financial Services held 1,000 shares of GenMark Diagnostics, Inc worth $5K as of Q4 2019.
Ladenburg Thalmann Financial Services sold 3,195 GenMark Diagnostics, Inc shares in Q4 2019, an estimated $17.6K.
GenMark Diagnostics, Inc made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4818 holding.
Ladenburg Thalmann Financial Services first reported a position in GenMark Diagnostics, Inc in Q1 2018 and has held it in 8 quarters since.
Ladenburg Thalmann Financial Services's GenMark Diagnostics, Inc position peaked at $31K in Q1 2019.
111 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.